Benzinga | Aug 4, 2021 04:32PM EDT

AtriCure Q2 EPS $(0.30) Beats $(0.33) Estimate, Sales $71.38M Beat $61.07M Estimate

AtriCure (NASDAQ:ATRC) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.33) by 9.09 percent. This is a 21.05 percent increase over losses of $(0.38) per share from the same period last year. The company reported quarterly sales of $71.38 million which beat the analyst consensus estimate of $61.07 million by 16.88 percent. This is a 74.84 percent increase over sales of $40.82 million the same period last year.